A Phase 1 Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2016
Price : $35 *
At a glance
- Drugs Lorcaserin (Primary)
- Indications Smoking withdrawal
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Eisai Inc
- 08 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 16 Sep 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
- 16 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.